95
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Matrix metalloproteinases -8, -9 and -12 in smokers and patients with Stage 0 COPD

, , , , , , & show all
Pages 369-379 | Published online: 20 Oct 2022

References

  • American Thoracic Society (ATS)1995Standards for the diagnosis and care of patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med152S771217582322
  • BarnesPJ2004Mediators of chronic obstructive pulmonary diseasePharmacol Rev565154815602009
  • BarnesPJShapiroSDPauwelsRA2003Chronic obstructive pulmonary disease: molecular and cellular mechanismsEur Respir J226728814582923
  • BeehKMBeierJKornmannO2003Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjectsRespir Med97634912814147
  • BrackeKCataldoDMaesT2005Matrix metalloproteinase-12 and cathepsin D expression in pulmonary macrophages and dendritic cells of cigarette smoke-exposed miceInt Arch Allergy Immunol1381697916192742
  • CalverleyPMWalkerP2003Chronic obstructive pulmonary diseaseLancet36210536114522537
  • CataldoDMunautCNoelA2000MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary diseaseInt Arch Allergy Immunol1232596711112863
  • CataldoDMunautCNoelA2001Matrix metalloproteinases and TIMP-1 production by peripheral blood granulocytes from COPD patients and asthmaticsAllergy561455111167375
  • ChurgAWangRDTaiH2003Macrophage metalloelastase mediates acute cigarette smoke-induced inflammation via tumor necrosis factor-alpha releaseAm J Respir Crit Care Med1671083912522030
  • CulpittSVRogersDFTravesSL2005Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthmaRespir Med997031015878486
  • DemedtsIKMorel-MonteroALebecqueS2006Elevated MMP-12 protein levels in induced sputum from patients with COPDThorax6119620116308335
  • DjukanovicRSterkPJFahyJV2002Standardised methodology of sputum induction and processingEur Respir J Suppl371s2s12361359
  • Ekberg-AronssonMPehrssonKNilssonJA2005Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitisRespir Res69816120227
  • ElkingtonPTFriedlandJS2006Matrix metalloproteinases in destructive pulmonary pathologyThorax612596616227332
  • GuedersMMBalbinMRocksN2005Matrix metalloproteinase-8 deficiency promotes granulocytic allergen-induced airway inflammationJ Immunol17525899716081833
  • HanemaaijerRSorsaTKonttinenYT1997Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycyclineJ Biol Chem2723150499395486
  • HautamakiRDKobayashiDKSeniorRM1997Requirement for macrophage elastase for cigarette smoke-induced emphysema in miceScience277200249302297
  • HigashimotoYYamagataYIwataT2005Increased serum concentrations of tissue inhibitor of metalloproteinase-1 in COPD patientsEur Respir J258859015863647
  • HoggJCChuFUtokaparchS2004The nature of small-airway obstruction in chronic obstructive pulmonary diseaseN Engl J Med35026455315215480
  • JonesCBSaneDCHerringtonDM2003Matrix metalloproteinases: a review of their structure and role in acute coronary syndromeCardiovasc. Res598122314553821
  • KangMJOhYMLeeJC2003Lung matrix metalloproteinase-9 correlates with cigarette smoking and obstruction of airflowJ Korean Med Sci18821714676438
  • KinnulaVL2005Focus on antioxidant enzymes and antioxidant strategies in smoking related airway diseasesThorax6069370016061713
  • KinnulaVLFattmanCLTanRJ2005Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapyAm J Respir Crit Care Med1724172215894605
  • LimSRocheNOliverBG2000Balance of matrix metalloprotease-9 and tissue inhibitor of metalloprotease-1 from alveolar macrophages in cigarette smokers. Regulation by interleukin-10Am J Respir Crit Care Med16213556011029344
  • MacCallumPK2005Markers of hemostasis and systemic inflammation in heart disease and atherosclerosis in smokersProc Am Thorac Soc2344316113467
  • ManninoDM2006GOLD Stage 0 COPD: Is it Real? Does it Matter?Chest1303091016899823
  • MercerPFShuteJKBhowmikA2005MMP-9, TIMP-1 and inflammatory cells in sputum from COPD patients during exacerbationRespir Res615116372907
  • MoletSBelleguicCLenaH2005Increase in macrophage elastase (MMP-12) in lungs from patients with chronic obstructive pulmonary diseaseInflamm Res5431615723202
  • NakamuraTEbiharaIShimadaN1998Effect of cigarette smoking on plasma metalloproteinase-9 concentrationClin Chim Acta27617379764735
  • NelsonKKMelendezJA2004Mitochondrial redox control of matrix metalloproteinasesFree Radic Biol Med377688415304253
  • OwenCAHuZBarrickB2003Inducible expression of tissue inhibitor of metalloproteinases-resistant matrix metalloproteinase-9 on the cell surface of neutrophilsAm J Respir Cell Mol Biol292839412663332
  • PauwelsRABuistASCalverleyPM2001Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summaryAm J Respir Crit Care Med16312567611316667
  • RahmanIAdcockIM2006Oxidative stress and redox regulation of lung inflammation in COPDEur Respir J282194216816350
  • RajagopalanSMengXPRamasamyS1996Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stabilityJ Clin Invest98257298958220
  • RussellRECulpittSVDeMatosC2002aRelease and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary diseaseAm J Respir Cell Mol Biol26602911970913
  • RussellREThorleyACulpittSV2002bAlveolar macrophagemediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteasesAm J Physiol Lung Cell Mol Physiol283L8677312225964
  • RytilaPRehnTIlumetsH2006Increased oxidative stress in asymptomatic current chronic smokers and GOLD stage 0 COPDRespir Res76916646959
  • RytilaPHLindqvistAELaitinenLA2000Safety of sputum induction in chronic obstructive pulmonary diseaseEur Respir J1511161910885433
  • SaettaMTuratoGMaestrelliP2001Cellular and structural bases of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1631304911371392
  • Segura-ValdezLPardoAGaxiolaM2000Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPDChest1176849410712992
  • ShapiroSD2002Proteinases in chronic obstructive pulmonary diseaseBiochem Soc Trans309810212023833
  • SorsaTSaloTKoivunenE1997Activation of type IV procollagenases by human tumor-associated trypsin-2J Biol Chem27221067749261109
  • StavemKSandvikLErikssenJ2006Can Global Initiative for Chronic Obstructive Lung Disease Stage 0 Provide Prognostic Information on Long-term Mortality in Men?Chest1303182516899828
  • TakafujiSIshidaAMiyakuniY2003Matrix metalloproteinase-9 release from human leukocytesJ Investig Allergol Clin Immunol13505
  • VernooyJHLindemanJHJacobsJA2004Increased activity of matrix metalloproteinase-8 and matrix metalloproteinase-9 in induced sputum from patients with COPDChest12618021015596677
  • VestboJLangeP2002Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease?Am J Respir Crit Care Med1663293212153965
  • ViljanenAA1982Reference values for spirometric, pulmonary diffusing capacity and body pletysmographic studiesScan J Clin Invest42suppl 159150
  • WillemseBWten HackenNHRutgersB2005Association of current smoking with airway inflammation in chronic obstructive pulmonary disease and asymptomatic smokersRespir Res63815850494
  • WoutersEF2005Local and systemic inflammation in chronic obstructive pulmonary diseaseProc Am Thorac Soc2263316113466